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Mitochondrial dynamics is a term that encompasses the movement of mitochondria
along the cytoskeleton, regulation of their architecture, and connectivity mediated
by tethering and fusion/fission. The importance of these events in cell physiology
and pathology has been partially unraveled with the identification of the genes
responsible for the catalysis of mitochondrial fusion and fission. Mutations in two
mitochondrial fusion genes (MFN2 and OPA1) cause neurodegenerative diseases,
namely Charcot-Marie Tooth type 2A and autosomal dominant optic atrophy (ADOA).
Alterations in mitochondrial dynamics may be involved in the pathophysiology of
prevalent neurodegenerative conditions. Moreover, impairment of the activity of
mitochondrial fusion proteins dysregulates the function of hypothalamic neurons, leading
to alterations in food intake and in energy homeostasis. Here we review selected findings
in the field of mitochondrial dynamics and their relevance for neurodegeneration and
hypothalamic dysfunction.
Keywords: mitochondrial fission, mitochondrial fusion, mitofusin 2, obesity, food intake, neurodegenerative
diseases
Introduction
Mitochondrial filaments were first reported in the mid-1800s upon the discovery of mitochondria.
However, it was not until the 1990s that the improvement of mitochondrial dyes permitted the
visualization of mitochondrial motion in different cellular models (Bereiter-Hahn and Voth, 1994;
Nunnari et al., 1997; Cortese et al., 1998). Mitochondrial dynamics alludes to the movement of
mitochondria along the cytoskeleton and also to changes in mitochondrial morphology, both
parameters being controlled by fusion and fission events, which in turn lead to these organelles
forming tubular or branched reticular networks.
The discovery of the first gene that participates in mitochondria fusion in Drosophila
melanogaster came about in 1997 (Hales and Fuller, 1997). In the last years, genes that participate
in mitochondrial fusion or fission have been identified (Yaffe, 1999). Although considerable
advances have been made in the field of mitochondrial dynamics in recent years, the molecular
elements that regulate fusion and fission remain unclear. In this regard, the physiological
relevance of mitochondrial dynamics in mammals is not precisely understood, and the proteins
that determine differences in mitochondrial morphology among distinct cell types need to be
clarified.
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Mitochondrial dynamics is required to facilitate inter-
mitochondrial complementation, and it also participates in
ensuring that mitochondria undergo maximal hyperfusion under
conditions of cellular stress (Chen and Chan, 2005; Tondera et al.,
2009). The fragmentation of mitochondria is also crucial in order
for these organelles to undergomitophagy (Twig et al., 2008), and
balanced mitochondrial dynamics is key to the maintenance of
an appropriate cell metabolism (Bach et al., 2003; Sebastian et al.,
2012).
Major Processes and Proteins Involved in
Mitochondrial Dynamics
Here we will review the proteins that participate inmitochondrial
fusion and mitochondrial fission.
The Mitochondrial Fusion Machinery
Mitochondrial compartmentalization is ensured by fusion of
the inner and outer mitochondrial membranes (Meeusen et al.,
2004). The main proteins involved in this process are the outer
membrane GTPases Mitofusins (Mfn1 and Mfn2) (Chen et al.,
2003; Ishihara et al., 2004) and the inner membrane GTPase
Optic atrophy 1 (OPA1) (Cipolat et al., 2004; Ishihara et al., 2006).
Mfn1 and Mfn2 are integral outer mitochondrial membrane
proteins and modulate mitochondrial morphology by promoting
mitochondria tethering and fusion (Koshiba et al., 2004). The
functions of Mfn1 and Mfn2 seems to overlap, since Mfn1
partially rescues the defects caused by Mfn2 mutation (Detmer
and Chan, 2007). Mfn1 and Mfn2 genes are widely expressed.
Mfn1 gene expression is high in heart and is expressed at lower
level in other human tissues. Mfn2 transcripts are abundant in
heart and skeletal muscle and present at lower levels in other
tissues (Santel et al., 2003).
Mfn1 shows two transmembrane domains at the C-terminus
of the protein, near a heptad-repeat (HR) domain (Santel et al.,
2003). The N-terminal region of Mfn1 contains a GTP-binding
domain followed by a heptad-repeat domain (HR1) (Santel
et al., 2003; Koshiba et al., 2004). The C-terminal HR domain
is considered to mediate the first step of mitochondrial fusion,
which consists of the tethering of two adjacent mitochondria
through the formation of a dimeric antiparallel coiled-coil
structure (Koshiba et al., 2004). These dimeric structures can be
homotypic (Mfn1-Mfn1 or Mfn2-Mfn2) or heterotypic (Mfn1-
Mfn2) (Chen et al., 2003; Koshiba et al., 2004). In addition, Mfn1
shows higher GTPase activity than Mfn2 (Ishihara et al., 2004).
In this respect, mitochondria containing Mfn1 show greater
tethering efficiency than mitochondria with Mfn2 (Ishihara et al.,
2004).
Mfn1 shows both transcriptional and post-transcriptional
or post-translational regulation (Santel et al., 2003). In this
regard, Mfn1 is regulated by PGC-1α during postnatal cardiac
growth (Martin et al., 2014). In contrast, Mfn1 is repressed
by dexamethasome in liver and in hepatoma cells (Hernandez-
Alvarez et al., 2013) and by microRNA 140 in cardiomyocytes
(Li et al., 2014). Regarding post-translational regulation, Mfn1
undergoes ubiquitination mediated by MARCH-V (also named
MITOL) or Parkin (Gegg et al., 2010; Park et al., 2010;
Tanaka et al., 2010; Park and Cho, 2012), and deacetylation
and activation mediated by HDAC6 (Lee et al., 2014). Mfn1
may be regulated through binding to MIB, a member of the
quinone oxidoreductase subfamily of zinc-containing alcohol
dehydrogenase proteins (Eura et al., 2006), and overexpression
of MIB induces mitochondrial fragmentation, whereas MIB
knockdown causes enhanced mitochondrial network structures
(Eura et al., 2006).
As mentioned, Mfn2 is an integral outer mitochondrial
membrane protein, which exposes both terminal ends to the
cytosol (Rojo et al., 2002). The N-terminal GTPase activity of
Mfn2 is key for its function in mitochondrial fusion (Chen
et al., 2003; Eura et al., 2003). Mfn2 is essential for embryonic
development, and ablation of Mfn2 causes placental dysfunction
(Chen et al., 2003). Mfn2 exerts a key role in brain, and
protects against neurodegeneration in the cerebellum (Chen
et al., 2007) as well as in dopaminergic neurons (Lee et al., 2012;
Pham et al., 2012). In addition, Mfn2 repression in neurons
leads to a delayed cell death upon excitotoxicity (Martorell-
Riera et al., 2014). Mfn2 has been proposed to regulate cell
proliferation and mitochondrial metabolism (Bach et al., 2003;
Chen et al., 2004a, 2014; Pich et al., 2005). In addition, this
protein promotes insulin signaling, and deficiency in muscle or
liver causes impaired insulin signaling caused by excessive JNK
activity and phosphorylation of IRS proteins at serine residues—
the latter inhibiting the capacity to activate PI-3 kinase and
downstream elements of the pathway (Sebastian et al., 2012).
Whether Mfn2 modulates insulin signaling in other tissues such
as brain, remains unknown.
The transcription factor Sp1 binds to and drives Mfn2
gene transcription both in skeletal muscle and in smooth
muscle cells (Sorianello et al., 2012). The transcription factor
Estrogen-Related Receptor-alpha (ERRα) also binds to the
human Mfn2 promoter and stimulates transcription (Soriano
et al., 2006). The transcription of Mfn2 is stimulated by the
coactivators PGC-1α and PGC-1β—key factors in mitochondrial
biogenesis (Scarpulla et al., 2012)— through physical/functional
interaction with ERRα (Soriano et al., 2006; Liesa et al., 2008).
Thus, PGC-1α or PGC1β overexpression induces Mfn2 in
cells (Soriano et al., 2006; Liesa et al., 2008). PGC-1β is also
necessary for the maintenance of Mfn2 in tissues, and PGC-
1β KO mice show reduced Mfn2 in metabolically-relevant
tissues (Liesa et al., 2008). In keeping with this, PGC-1β
influences mitochondrial morphology through the promotion of
mitochondrial elongation, and enhanced mitochondrial fusion
(Liesa et al., 2008). Interestingly. overexpression of PGC-1β
causes mitochondrial elongation in wild-type, and in Mfn1
KO MEF cells. However, such overexpression does not cause
mitochondrial elongation in Mfn2 KO MEF cells (Liesa et al.,
2008), which suggests that Mfn2 is required for the effects
of PGC-1βon mitochondrial morphology. These data are also
consistent with the reduced mitochondrial volume, independent
of changes in mitochondrial number, detected in muscle from
PGC-1βKOmice (Lelliott et al., 2006; Liesa et al., 2008). Based on
all those evidences, Mfn2 undergoes transcriptional regulation.
In addition to this mechanism of control, Mfn2 is regulateded
by proteasomal degradation. In this respect, Mfn2 undergoes
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ubiquitination catalyzed by Parkin (Gegg et al., 2010; Poole
et al., 2010; Tanaka et al., 2010; Ziviani et al., 2010). Mfn2
is also ubiquitinated by the E3 ubiquitin ligases HUWE1,
regulated by phosphorylation of JNK, and by the ubiquitin
ligase Mul1 (Leboucher et al., 2012; Lokireddy et al., 2012).
The processes of Mfn2 ubiquitination lead to Mfn2 degradation.
The ubiquitin ligase MARCH-V (or MITOL) catalyzes lysine-
63-linked polyubiquitination of Mfn2 but does not drive its
proteasomal degradation (Sugiura et al., 2013). Mfn2 levels are
also regulated by activation of the deubiquitinase USP30 (Yue
et al., 2014).
Optic atrophy gene 1 (OPA1) is also a dynamin-related
protein with GTPase activity. This protein is located in the
intermembrane space, in the inner mitochondrial membrane
and in the cristae volume (Misaka et al., 2002; Olichon et al.,
2002; Satoh et al., 2003). OPA1 is essential for mitochondrial
fusion (Cipolat et al., 2004; Chen et al., 2005). OPA1 shows high
expression in brain, retina, liver, heart, skeletal muscle, and testis
(Delettre et al., 2001; Cipolat et al., 2004). OPA1 maintains the
normal structure of the optic nerve (Davies et al., 2007), and
its deficiency causes alterations in the dendritic morphology of
retinal ganglion cells (Williams et al., 2010). In addition, OPA1
promotes neuronal survival following excitotoxicity (Jahani-Asl
et al., 2011).
Various OPA1 isoforms have been identified (Olichon et al.,
2003; Cipolat et al., 2004; Griparic et al., 2004; Ishihara
et al., 2006). The existence of multiple OPA1 isoforms and
cleavage mechanisms may explain the role of this protein
beyond mitochondrial inner membrane fusion, such as in cristae
remodeling, supercomplex formation, and in the regulation of
the selective fusion that determines mitochondrial autophagy
(Frezza et al., 2006; Twig et al., 2008; Cogliati et al., 2013). OPA1
isoforms are generated from a single gene through alternative
splicing and proteolysis. OPA1 isoforms are named as long and
short on the basis of their electrophoretic mobility (Delettre
et al., 2001; Olichon et al., 2007; Akepati et al., 2008). Both short
and long forms are required for mitochondrial fusion, and thus
constitutive OPA1 cleavage is required for efficient mitochondrial
fusion (Song et al., 2007; DeVay et al., 2009). Some long
OPA1 isoforms are constitutively cleaved by the intermembrane
space AAA protease YME1L (Griparic et al., 2007; Song et al.,
2007). The cleavage of OPA1 is also induced by mitochondrial
depolarization, which reduces the abundance of long isoforms,
increases the short OPA1 isoforms, and reduces mitochondrial
fusion. This inducible OPA1 cleavage is also activated by ATP
deficiency and by apoptosis (Baricault et al., 2007; Griparic et al.,
2007) and it is catalyzed by the zinc metalloprotease OMA1
(Ehses et al., 2009; Head et al., 2009; Quiros et al., 2012). In this
respect, OMA1 ablation causes a deficient mitochondrial activity
and function in brown adipose tissue, and obesity (Quiros et al.,
2012).
The Mitochondrial Fission Machinery
Mitochondrial fission describes the fragmentation of a
mitochondrion into two. This process is necessary to drive
damaged mitochondria through mitophagy (Kim et al., 2007),
to pass mitochondria to daughter cells during mitosis, and
to regulate apoptosis (Lee et al., 2004). Alterations in fission
machinery increase the generation of reactive oxygen species
(ROS) and lead to a heterogeneous population of mitochondria
with non-uniform mitochondrial DNA distribution (Parone
et al., 2008).
Dynamin-related protein 1 (Drp1) plays a key role in the
catalysis of mitochondrial fission. Drp1 is a cytosolic protein
that is recruited to the outer mitochondrial membrane, where
it catalyzes mitochondrial division. Drp1 interacts with the
mitochondrial proteins fission protein 1 homolog (Fis1), the
mitochondrial fission factor (Mff), MiD49, and MiD51.
Drp1 is found mainly in the cytosol and, as a member of
the dynamin protein family, it contains a GTPase domain and
a GTPase effector domain. Drp1 assembles into multimeric
ring complexes at mitochondrial fission sites, which leads to
constriction following GTP hydrolysis to promote division
(Bleazard et al., 1999; Van Der Bliek, 1999; Legesse-Miller et al.,
2003; Ingerman et al., 2005; Lackner et al., 2009; Mears et al.,
2011). Given that Drp 1 lacks domains involved in membrane
binding, the recruitment of this molecule at the mitochondrial
outer membrane requires the involvement of membrane proteins
that act as receptors (Parone et al., 2008).
Drp1 is regulated by post-translational modifications
such as S-nitrosylation, sumoylation, ubiquitination, and
phosphorylation of serine residues, and they may regulate its
recruitment to the mitochondria. S-nitrosylation enhances
the pro-fission activity of Drp1 by inducing dimerization
and enhancing GTPase activity (Cho et al., 2009). Drp1 S-
nitrosylation and mitochondrial fragmentation have been
detected by the ß-amyloid protein (Aβ), a mediator of
Alzheimer’s disease (AD) (Head et al., 2009). Drp1 can
be also activated by sumoylation (Wasiak et al., 2007). Thus,
SUMO-1 and its conjugating enzymeUbc9 inducemitochondrial
fission by stabilizing Drp1 (Harder et al., 2004). In contrast, the
sentrin/SUMO-specific protease SENP5 reduces Drp1 levels,
which reduces mitochondrial fission (Zunino et al., 2009). In
addition, it has been proposed that MARCH V, a mitochondrial
E3 ubiquitin ligase, participates in the translocation of Drp1 to
mitochondria independently of changes in stability (Karbowski
et al., 2007). Phosphorylation occurs on Ser616 and Ser637 (in
reference to the human Drp1 sequence). Phosphorylation of
Ser616 by cyclin-dependent kinase 1 (Cdk1/cyclin B) causes
Drp1 recruitment to the mitochondria (Taguchi et al., 2007).
Phosphorylation of Ser637 is catalyzed by protein kinase A
(PKA), Calmodulin-dependent kinase, and Pim1 (Chang and
Blackstone, 2007; Cribbs and Strack, 2007), and it inhibits Drp1
function. Dephosphorylation of the Ser637 residue by the protein
phosphatase calcineurin recruits Drp1 to the mitochondria and
promotes fission (Cribbs and Strack, 2007; Cereghetti et al.,
2008).
Drp1 ablation in mice causes embryonic lethality. Drp1
knockout embryos present alterations in liver and heart
development, increased apoptosis within the deep neural cortex,
and deficient synapse formation (Ishihara et al., 2009). In
addition, Drp1 loss-of-function delays cytochrome c release
during apoptosis, thereby suggesting that this release is linked to
mitochondrial fission (Ishihara et al., 2009).
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The recruitment of the Drp1 ortholog in yeast (Dnm1)
from the cytosol to the outer mitochondrial membrane occurs
through association with the protein Fis1, resulting in the
formation of a fission complex (Mozdy et al., 2000; Legesse-
Miller et al., 2003; Yoon et al., 2003; Karren et al., 2005).
Mammalian Fis1 is a small ubiquitous 17.2-kDa protein found
throughout the mitochondrial network. Fis1 is anchored into
the outer mitochondrial membrane via its COOH terminal
part, which contains an alpha-helix, a transmembrane domain,
and a COOH-terminal tail exposed to the inter-membrane
space. The NH2-terminal part of the protein contains four
distinct regions with five alpha-helices (Suzuki et al., 2003;
Dohm et al., 2004); the first alpha-helix of Fis1 has been
reported to be critical for its oligomerization and fission activity
(Jofuku et al., 2005). The subsequent four alpha-helices make up
two tetratrico-peptide repeat peptides, which are not required
for Fis1 oligomerization but they participate in the protein-
protein interactions required for fission (Jofuku et al., 2005).
Overexpression of Fis1 causes mitochondrial fragmentation,
whereas knockdown of this protein results in the formation
of a highly fused mitochondrial network, thereby indicating
that Fis1 activates mitochondrial fission (Mozdy et al., 2000;
Yoon et al., 2003; Stojanovski et al., 2004; Karren et al., 2005).
However, the observations that Drp1 can still be recruited
to the mitochondrial outer membrane following knockdown
of Fis1 (Lee et al., 2004; Wasiak et al., 2007) suggest that
other proteins also participate in mammalian mitochondrial
fission.
Mff (Gandre-Babbe and van der Bliek, 2008; Otera et al.,
2010) is anchored to the outer mitochondrial membrane and
it can recruit Drp1 independently of Fis1 (Otera et al., 2010).
Absent in yeast, Mff represents a more recent acquisition of the
mitochondrial fission machinery that is active in mammalian
cells. Mff localizes in discrete sites on mitochondria, and its
overexpression causes recruitment of Drp1 to mitochondria and
mitochondrial fragmentation. Conversely, Mff deficiency leads
to reduced Drp1 at the mitochondrial and to mitochondrial
elongation (Otera et al., 2010).
MiD49 and MiD51 proteins share 65% identity and are
anchored to the mitochondrial outer membrane through their
N-terminal end (Simpson et al., 2000; Palmer et al., 2011). Like
Drp1, MiD49/51 form puncta and rings around mitochondria.
MiD49/51 recruit Drp1 to the mitochondria, whereas their
loss-of-function reduces mitochondrial Drp1 association. Co-
immunoprecipitation experiments have established that MiD49
interacts with Drp1. MiD49 and MiD51 can act independently of
both Mff and Fis 1 (Loson et al., 2013).
Located in the outer mitochondrial membrane, ganglioside-
induced differentiation-associated protein 1 (GDAP1) has been
proposed to participate in mitochondrial fission (Cassereau
et al., 2011). GDAP1 gain-of-function causes mitochondrial
fragmentation, while its deficiency results in mitochondrial
elongation (Niemann et al., 2005). Genetic manipulation of
the Drosophila ortholog Gdap1 also leads to changes in the
size, morphology and distribution of mitochondria and in
neuronal and muscular degeneration (Lopez Del Amo et al.,
2015).
Interaction of the Endoplasmic Reticulum
and Mitochondria: Role of Proteins
Involved in Mitochondrial Dynamics
Close appositions between the endoplasmic reticulum (ER)
and mitochondria or mitochondria-ER contact sites have been
observed by electron microscopy in fixed samples of several
cell types and are unexplainable by fixation artifacts. These
regions represent the sites of phospholipid exchange between
the two organelles. The close contacts through which the
ER communicates with mitochondria have been biochemically
purified and are referred to as the mitochondria-associated
ER membrane (MAM) (Vance, 1990). The interaction between
mitochondria and the ER is crucial in mediating organelle-
organelle signals, such as metabolic stress or cell death cues
(Figure 1).
Mitochondria tethering to the ER via the MAM is a dynamic
process. These ER-contiguous membranes contain multiple
phospholipid- and glycosphingolipid-synthesizing enzymes,
including long-chain fatty acid-CoA ligase type 4 (FACL4) and
phosphatidylserine synthase-1, and they support the direct
transfer of lipids between the ER and mitochondria (Stone and
Vance, 2000; Cardenas et al., 2010). In addition to supporting
lipid transfer, MAMs also exchange Ca2+ ions, which regulate
processes such as ER chaperone-assisted folding of newly
synthesized proteins and enzymes with dehydrogenase activity
(Berridge, 2002). In this regard, the truncated variant of the
sarcoendoplasmic reticulum Ca2+-ATPase 1 (SERCA1T) is
induced during ER stress, promotes the transfer of calcium from
the ER to mitochondria, and induces apoptosis (Chami et al.,
2008). Nearly 30 proteins that play relevant roles in organelle
homeostasis are found in this compartment. Furthermore,
proteomic studies of mouse brain MAM fractions have identified
about 1000 proteins localized in MAMs (Poston et al., 2013).
Chaperones, ion channels, proteins of mitochondrial dynamics,
and metabolic enzymes are among the molecules detected
in MAMs. Thus, the chaperone GRP-75 links the outer
mitochondrial membrane protein VDAC with the N-terminus
of the inositol 1,4,5-trisphosphate receptor (IP3R), and GRP-75
deficiency reduces calcium transfer from the ER to mitochondria
(Szabadkai et al., 2006) (Figure 2). Another MAM-localized
protein is the Sigma-1 receptor chaperone. Sigma-1 binds GRP-
78 and its overexpression counteracts the ER stress response
and prevents apoptosis mediated by the release of ER calcium
(Hayashi and Su, 2007). PACS2, another protein localized in
MAMs, is involved in the ER-mitochondria interaction. PACS2
silencing causes mitochondria and ER fragmentation and
also ER stress characterized by enhanced GRP-78 expression
and reduced apoptosis (Simmen et al., 2005). The ER protein
Nogo also alters the ER-mitochondria unit (Sutendra et al.,
2011).
Mfn2 was initially identified as a mitochondria fusion
protein. However, it also plays a critical role in maintaining ER
morphology by tethering mitochondria and the ER (de Brito
and Scorrano, 2008) (Figure 3). Mfn2 null mouse embryonic
fibroblasts (MEFs) show a fragmented ER network, and
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FIGURE 1 | ER–mitochondria contact sites. The ER interacts with mitochondria through close contacts that permit the transfer of calcium from the ER to
mitochondria and that permit the exchange of lipids between those two organelles (A). The ER also interacts with mitochondria through mitochondrial fission sites (B).
FIGURE 2 | Proteins and processes involved in the ER-mitochondria contact sites. Contact sites involve, among others, the exchange of phosphatidylserine
(PS) and phosphatidylethanolamine (PE) between the ER and mitochondria and the formation of complexes between the ER and mitochondrial proteins, as shown.
the contact regions between mitochondria and the ER are
significantly reduced (de Brito and Scorrano, 2008). In keeping
with this view, Mfn2 loss-of-function in cells or in tissues such as
muscle, liver or hypothalamus causes ER stress (Sebastian et al.,
2012; Munoz et al., 2013; Schneeberger et al., 2013). Moreover,
Mfn2 deficiency causes chronic activation of PERK, a process
that plays a relevant role in the alterations detected under these
conditions (Figure 3). Thus, PERK deficiency inMfn2 null MEFs
reduces ROS production, normalizes mitochondrial calcium, and
improves mitochondrial morphology (Munoz et al., 2013).
Other proteins involved in mitochondrial dynamics, such as
Drp1 and Fis1, are also associated with ER-mitochondria contact
sites (Pitts et al., 1999; Iwasawa et al., 2011). In mammalian
cells, the ER tubules contact the mitochondrial membrane at
constriction sites marked by Drp1 and its receptor the Mff
protein (Friedman et al., 2011). In fact, Drp1 andMff are markers
for ER-mitochondria contact sites. The ER-mitochondria contact
is not disrupted by Drp1 or Mff depletion, thereby suggesting
that such interactions are independent of division machinery
recruitment (Friedman et al., 2011). Contact with the ER is
therefore a feature of mitochondrial fission sites (Figure 1). This
contact is also maintained after mitochondrial fission.
In all, alterations in the expression of Mfn2 lead to the
disruption of ER-mitochondria communications and the ER
plays a key role in the localization of mitochondrial fission sites.
Mutations in Genes Involved in
Mitochondrial Dynamics Cause
Neurodegenerative Disorders
In the nervous system, mitochondria are essential for energy
production, calcium regulation, maintenance of plasma
membrane potential, protein folding by chaperones, axonal
and dendritic transport, and release and re-uptake of
neurotransmitters at synapses. In the last years, mitochondrial
dynamics has been reported to participate in the pathophysiology
of neuronal disorders. In this respect, mutations in genes
involved in mitochondrial dynamics have been shown to cause
neuronal disorders.
Autosomal Dominant Optic Atrophy
Autosomal dominant optic atrophy (ADOA) has an estimated
prevalence ranging from 1:12,000 to 1:50,000 and it is the most
Frontiers in Aging Neuroscience | www.frontiersin.org 5 June 2015 | Volume 7 | Article 101
Zorzano and Claret Mitochondrial dynamics, neurodegeneration, and the hypothalamus
FIGURE 3 | Roles of Mfn2 on ER-mitochondria contact sites. Mfn2 participates in the tethering of mitochondria and the ER at contact sites. In addition, Mfn2
negatively regulates PERK, a protein kinase involved in the Unfolded Protein Response (UPR) and activated upon ER stress.
common form of inherited optic neuropathy. This disease is
characterized by visual impairment in early childhood with
moderate to severe loss of visual acuity, temporal optic disc
pallor, abnormalities of color vision, and caecocentral visual
field scotoma (Hoyt, 1980; Votruba et al., 1998; Johnston et al.,
1999). Histopathological analysis suggests that the fundamental
pathology of ADOA is a primary degeneration of retinal ganglion
cells, followed by increasing atrophy of the optic nerve (Johnston
et al., 1979; Kjer et al., 1983).
Most families with ADOA show pathogenic mutations in
the OPA1 gene (Olichon et al., 2006). More than 200 OPA1
gene mutations have been identified—these basically family-
specific (Ferré et al., 2005). OPA1 mutations involve mainly
substitutions, but also deletions and insertions (Delettre et al.,
2001; Olichon et al., 2006). Near 50% of the mutations cause
truncation of the OPA1 protein, and most of the mutations are
detected in the GTPase domain and are thus likely to eliminate
mitochondrial fusion. The pathogenesis of ADOA occurs, in
most cases, as a result of haploinsufficiency (loss-of-function,
Delettre et al., 2000). In this regard, OPA1 deficiency in mice
induced by in-frame deletion of 27 amino acid residues in the
GTPase domain or non-sense mutations causes the degeneration
of retinal ganglion cells and disorganized mitochondrial cristae
of optic nerve axons (Alavi et al., 2007; Davies et al., 2007). In
addition to haploinsufficiency, ADOA can also develop as a result
of a dominant negative mechanism (Delettre et al., 2000; Pesch
et al., 2001; Baris et al., 2003; Kim et al., 2005).
Some human OPA1 mutations cause a specific form of
disease, characterized by myopathy and progressive external
ophtalmoplegia (Hudson et al., 2008), and has been named
“OPA1 plus syndrome.” This syndrome is also characterized
by reduced mitochondrial DNA copy number. In keeping
with this, patients with certain OPA1 mutations show multiple
deletions in mitochondrial DNA in skeletal muscle (Amati-
Bonneau et al., 2008; Hudson et al., 2008), and mice carrying the
Opa1(delTTAG) mutation (found in 30% of all human patients
with ADOA) show a multi-systemic phenotype (Sarzi et al.,
2012).
Mfn2 Mutations: Charcot-Marie-Tooth Type 2A
Charcot-Marie-Tooth (CMT) disease is clinically characterized
by weakness and distal muscle atrophy, predominantly of
the lower extremities, and by sensory loss. CMT affects
approximately 1 in 2500 individuals, thus making this condition
one of the most common hereditary diseases and the most
common hereditary neuropathy (Skre, 1974).
CMT2 is characterized by chronic axonal degeneration and
regeneration, leading to steady loss of nerve fibers with normal
or slightly reduced motor nerve conduction velocities (≥38m/s)
(Dyck and Lambert, 1968). Mutations in MFN2 cause 20% of
CMT2 cases (Lawson et al., 2005), and this the most prevalent
axonal form of CMT. CMT2 cases show high variability in clinical
symptoms. Furthermore, MFN2mutations have been detected in
CMT2 families and are associated with additional features such as
spasticity (Zhu et al., 2005) and atrophy (Verhoeven et al., 2006).
Most of the MFN2 mutations found in CMT2A patients are
missense (Zuchner et al., 2004; Kijima et al., 2005; Lawson et al.,
2005; Zhu et al., 2005; Chung et al., 2006; Engelfried et al., 2006;
Verhoeven et al., 2006). More than 50% are detected in the
GTPase domain but they do not affect GTP binding (Baloh et al.,
2007). In addition, MFN2 mutations have been detected in the
following sites: in the NH2-terminal region; near or at the Ras-
binding domain; in the vicinity of or at the HR1 region; and in
the COOH terminus, specifically in the HR2 region, facing the
cytoplasmic site.
The mutations of MFN2 responsible for CMT2A show
autosomal dominant inheritance; consequently, they may show
haploinsufficiency or a dominant gain-of-function. In keeping
with this view, the overexpression of some mutant forms of
MFN2 induces the aggregation of mitochondria in cultured
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rat dorsal root ganglion neurons and in MEFs, indicating the
promotion of gain-of-function (Baloh et al., 2007; Detmer and
Chan, 2007). The defective mitochondrial fusion activity of some
Mfn2 mutants is rescued by Mfn1 gain-of-function, which is in
keeping with the observation thatMfn1 physically associates with
wild-type Mfn2 and mutant forms of CMT2A (Loiseau et al.,
2007; Amiott et al., 2008).
Transgenic mice have been generated to express a mutant
form of MFN2 with a presumed gain-of-function (T105M)
specifically in motor neurons. These mice show a phenotype
consistent with the clinical symptoms detected in CMT2A, and
provide a system to determine the function of mitochondria in
the axons of motor neurons (Detmer et al., 2008).
GDAP1 mutations are associated with type 4A CMT
(CMT4A), the most frequently detected recessive form of CMT
(Baxter et al., 2002; Cuesta et al., 2002). CMT4 is classically
defined as a demyelinating form of the disease and it is associated
with segmental de- and re-myelination, in contrast to CMT2,
which shows axonal degeneration without demyelination (Berger
et al., 2002; Suter and Scherer, 2003). However, analysis of
the nerve conduction rates of subjects with GDAP1 mutations
indicates that while some mutations show low nerve conduction
rates (Baxter et al., 2002; Ammar et al., 2003; Senderek et al.,
2003), others are characterized by normal rates (Nelis et al., 2002;
Ammar et al., 2003; Boerkoel et al., 2003; De Sandre-Giovannoli
et al., 2003; Sevilla et al., 2003). These data demonstrate that
some of the GDAP1 mutations cause axonal loss rather than
demyelinization.
Mitochondrial Dynamics and Prevalent
Neurodegenerative Diseases
Both fusion and fission mechanisms participate in the
mitochondrial life cycle and any disruption of their balance can
alter the steady-state distribution of mitochondria. Specifically
in neurons, the mitochondrial fusion/fission machinery is
intimately and critically involved in the formation of synapses
and dendritic spines. Thus, alterations in mitochondrial
dynamics prevent these organelles from distributing to synapses,
thus leading to a loss of mitochondria from dendritic spines
and, consequently, to a reduction of synapse formation (Li
et al., 2004). The mitochondrial dynamics proteins that control
the distribution of mitochondria in dendrites also regulate
the density and plasticity of synapses (Li et al., 2004). Thus,
dominant-negative Drp1 or OPA1 overexpression (both of
which reduce dendritic mitochondria) causes a decreased
density of spines and synapses (Li et al., 2004). Consistent
with this view, Drp1 ablation in mice shows developmental
abnormalities, particularly in the forebrain (Ishihara et al.,
2009). Given these considerations, a strong association between
the expression/activity of proteins involved in mitochondrial
dynamics and neurodegenerative diseases can be expected.
In this regard, brains from AD patients show fragmented
and perinuclear mitochondria (Cho et al., 2009; Wang et al.,
2009a), paralleled by increased expression of Fis1 and decreased
expression of the fusion proteins Mfn1, Mfn2, and OPA1
(Wang et al., 2009a; Reddy et al., 2011). These data suggest
that abnormal mitochondrial dynamics in neurons of AD
patients may participate in the pathogenesis of the disease.
In line with these observations, brains from AD patients
show altered lipid metabolism (Schon and Area-Gomez, 2010),
aberrant calcium homeostasis (Supnet and Bezprozvanny,
2010), enhanced unfolded protein response (UPR) (Hoozemans
et al., 2005), and defects in energy metabolism (Ferreira
et al., 2010). As to the factors responsible for mitochondrial
dysfunction, overexpression of amyloid precursor protein
(APP) or exposure to amyloid beta peptide (Abeta) induces
mitochondrial fragmentation and abnormal distribution (Rui
et al., 2006; Wang et al., 2008). Furthermore, exposure of
neurons to oligomerized Abeta leads to S-nitrosylation of
Drp1, causing mitochondrial fragmentation (Cho et al., 2009).
Upregulated MAM function at the ER-mitochondrial interface
and increased cross-talk between these two organelles has been
reported in presenilin-mutant cells, and it may participate in the
pathogenesis of AD (Area-Gomez et al., 2012).
Complex I activity is reduced in the substantia nigra of
subjects with Parkinson’s disease (PD), and various complex
inhibitors (MPP+, rotenone, and other pesticides) cause
neuropathological changes similar to those observed in PD
(Schapira et al., 2006). In this regard, rotenone and 6-
hydroxydopamine have been shown to induce Drp1-dependent
mitochondrial fragmentation in neuronal cells (Barsoum et al.,
2006; Gomez-Lazaro et al., 2008). Mutations in Parkin and outer
membrane kinase PTEN-induced putative kinase-1 (PINK1)
have been reported in familial PD, and these proteins participate
in a major mitochondrial quality control pathway (Pickrell and
Youle, 2015). When the mitochondrial membrane potential
decreases, PINK1 recruits Parkin to the mitochondria (Narendra
et al., 2010). Parkin next ubiquitinates PINK1, thus trigering
mitophagy. Parkin also ubiquitinates other targets such as Mfn1,
Mfn2, Fis1, and Drp1, causing their proteasomal degradation
(Tanaka et al., 2010; Ziviani et al., 2010; Chan et al.,
2011; Wang et al., 2011). In agreement, loss of function of
PINK1 or Parkin causes mitochondrial fragmentation (Exner
et al., 2007; Lutz et al., 2009; Sandebring et al., 2009), and
mammalian fibroblasts carrying PINK1 mutations from PD
patients also exhibit mitochondrial fragmentation (Grunewald
et al., 2009).
Huntington’s disease (HD) is caused by an expansion of
a CAG trinucleotide sequence that encodes a polyglutamine
tract in the huntingtin protein. Mitochondrial dysfunction
is also associated with the pathogenesis of HD (Brouillet
et al., 1995; Tabrizi et al., 1999; Panov et al., 2002; Schapira
et al., 2014). Thus, the striatum and frontal cortex of HD
patients show an increased abundance of Fis1 and Drp1
(Costa et al., 2010) and decreased levels of Mfn1, Mfn2, and
OPA1 (Shirendeb et al., 2011). This pattern of changes may
lead to mitochondrial fragmentation in these subjects. As to
the mechanisms responsible for mitochondrial fragmentation,
overexpression of mutant huntingtin causes mitochondrial
fragmentation and blockade of fragmentation prevents the
cytotoxic effects of mutant huntingtin (Wang et al., 2009b).
Furthermore, mutant huntingtin binds to Drp1 and enhances
its GTPase activity (Song et al., 2011). In all, these studies
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support the notion that alterations in mitochondrial dynamics
are involved in the pathogenesis of HD.
Hypothalamic Neuronal Circuits and
Mitochondrial Function
The maintenance of energy homeostasis is fundamental to
sustain life. In mammals, the central nervous system (CNS) plays
a critical role in the regulation of appetite, energy expenditure,
and metabolism through multiple and distributed neuronal
circuits. The hypothalamus, which is made up of distinct
nuclei, including the arcuate nucleus (ARC), the paraventricular
nucleus, the lateral area, the dorsomedial nucleus and the
ventromedial nucleus, is arguably the most important CNS
region in metabolic control (Schneeberger et al., 2014). Extensive
experimental evidence indicates that ARC is a key area in the
neural hierarchy that regulates this biological process. The ARC
holds at least two subsets of neurons—with opposite functions
and reciprocally regulated—involved in systemic energy
balance control. One set co-expresses orexigenic neuropeptides
Agouti-related protein (AgRP) and Neuropeptide Y (NPY),
while the other co-expresses anorexigenic neuropeptides
cocaine- and amphetamine-regulated transcript (CART) and
α-melanocyte-stimulating hormone (α-MSH, a product of
proopiomelanocortin (POMC) processing) (Schneeberger et al.,
2014).
The Melanocortin System
POMC and AgRP neurons, together with downstream neurons
expressing melanocortin receptors (MCR) 3 and 4, form the
melanocortin system, a crucial neuronal circuit that senses and
responds to fluctuations in central and circulating factors that
inform about the nutritional status of the organism. Indeed,
the activity of these two subsets of neurons is influenced
by local (NPY, serotonin, GABA, etc.) and peripheral (leptin,
insulin, ghrelin) signals, as well as by nutrients such as glucose
and free fatty acids. Numerous pharmacological and genetic
studies indicate that the divergent physiological roles of these
two populations of neurons are largely the consequence of
the release and action of α-MSH and AgRP neuropeptides. α-
MSH is an endogenous agonist of MCR3 and 4, thus providing
an anorexigenic tone by suppressing appetite and increasing
thermogenesis (Poggioli et al., 1986; Wirth et al., 2001). In
contrast, AgRP is an antagonist of these receptors and therefore
counteracts the effects of α-MSH signaling on food intake and
body weight (Ollmann et al., 1997). In addition, the orexigenic
actions of AgRP neurons are also mediated by the release of
NPY, which binds to specific receptors, and by direct GABAergic
synapsis onto POMC neurons (Cowley et al., 2001).
In summary, current evidence indicates that a local ARC
circuit constituted by “first order” POMC and AgRP neurons
plays a critical role in sensing, integrating, and responding to
humoral signals that report on energy status. These neurons
engage downstream “second order”multi-level neurocircuits that
will produce precise effector responses. The global integration
of these signals culminates in the generation of coordinated
behavioral, autonomic, and neuroendocrine responses to regulate
appetite, energy expenditure, and body weight (Schneeberger
et al., 2014).
Leptin and Ghrelin: Key Hormones Regulating
Energy Homeostasis
Leptin and ghrelin are prototypical examples of metabolic signals
of energy surfeit and deficit respectively, and POMC and AgRP
neurons are direct targets of both hormones (Cheung et al.,
1997; Elias et al., 1999; Willesen et al., 1999; Cowley et al.,
2001). Leptin exerts its anorexigenic effects by increasing Pomc
expression and processing into α-MSH (Schwartz et al., 1997;
Thornton et al., 1997; Mizuno et al., 1998), and by inhibiting
bothNpy and AgRP transcription (Stephens et al., 1995; Schwartz
et al., 1996; Mizuno and Mobbs, 1999). Leptin also increases the
electrical activity of POMC neurons, thereby leading to α-MSH
release (Cowley et al., 2001; Claret et al., 2007; Hill et al., 2008;
Al-Qassab et al., 2009). In addition to its agonism/antagonism
effects onMCRs, leptin attenuates the inhibitory GABAergic tone
of AgRP neurons onto POMC neurons (Cowley et al., 2001).
Similarly, recent data showed that leptin also acts on non-AgRP
presynaptic GABAergic neurons by reducing the inhibitory input
on POMCneurons (Vong et al., 2011). Overall, these effects result
in reduced food intake and increased energy expenditure.
Under conditions of negative energy balance, circulating
ghrelin levels are increased. Evidence indicates that the
orexigenic effects of ghrelin are largely mediated by AgRP
neurons (Chen et al., 2004b; Luquet et al., 2007; Wang et al.,
2014). Consistently, ghrelin enhances Npy and AgRP transcript
expression (Kamegai et al., 2001; Nakazato et al., 2001).
The release of AgRP and NPY hyperpolarizes neighboring
POMC neurons, thus reducing α-MSH release (Roseberry
et al., 2004; Smith et al., 2007; Cyr et al., 2013). Furthermore,
electrophysiology studies have shown that ghrelin activates AgRP
neurons and increases the number of inhibitory synapses onto
POMC neurons (Cowley et al., 2003; Yang et al., 2011; Atasoy
et al., 2012). Collectively, these events lead to the simultaneous
activation of AgRP neurons and inhibition of POMC neurons,
thus enhancing the orexigenic output.
Mitochondrial Function in Hypothalamic ARC
Neurons
Neurons are highly energy-demanding, and thus adequate
mitochondrial performance is essential for the growth, survival,
and function of these cells (Zhu et al., 2012). Mitochondrial ATP
production and Ca2+ buffering/release are fundamental for a
myriad of neuronal functions, including synapse assembly, action
potential generation, and synaptic transmission, amongst others.
Given their particular and intricate morphology, neurons require
the distribution of mitochondria to distal areas in order to cover
the high energy demands associated with a number of specialized
functions. Thus, mitochondrial function and dynamics must be
tightly regulated in order to temporally and spatially satisfy the
bioenergetic needs of neurons.
Despite the paramount importance of the regulation of
systemic energy balance and metabolism by mitochondria in
hypothalamic neurons, few studies have addressed this issue.
An important aspect to note is the diametrically different
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bioenergetic patterns of POMC and AgRP neurons, which
are largely the consequence of their divergent physiological
functions. Negative energy balance acutely activates AgRP
neurons and promotes mitochondrial uncoupling activity
associated with elevated mitochondrial density (Coppola et al.,
2007; Dietrich et al., 2013). Under these conditions, ghrelin-
induced β-oxidation constitutes the main energy supply to
maintain AgRP neuron activity. This is achieved through an
axis formed by the AMP-activated protein kinase (AMPK) and
the muscle isoform of carnitine O-palmitoyltransferase 1 (CPT1-
M) (Andrews et al., 2008; Lopez et al., 2008) which allows
the uptake of long-chain fatty acyl CoAs by the mitochondria
and the subsequent β-oxidation. A key component of this
process is uncoupling protein 2 (UCP2), a mitochondrial protein
that mediates proton leak, thereby limiting ATP and ROS
production (Mailloux and Harper, 2011). Hypothalamic UCP2
expression is induced by fasting (Coppola et al., 2007), and
ghrelin-driven feeding by AgRP requires UCP2 (Andrews et al.,
2008). In line with these observations, fasting and ghrelin
increase mitochondrial proliferation, synaptic plasticity, and
electric activity of AgRP neurons in a UCP2-dependent manner
(Coppola et al., 2007; Andrews et al., 2008). Under conditions
of positive energy balance, when circulating leptin and glucose
levels are high, POMC neurons increase their firing rate while
AgRP neurons remain silent (Claret et al., 2007; Parton et al.,
2007). Consistently, feeding conditions are associated with
increased mitochondrial number in POMC neurons (Diano
et al., 2011). The current model suggests that cellular glucose
metabolism in POMC neurons generates a high proton gradient,
concomitant with elevated ATP and ROS production. ATP
would inactivate ATP-sensitive potassium (KATP) channels and
depolarize POMC neurons (Ibrahim et al., 2003). In addition,
enhanced ROS levels would activate POMC neurons, further
contributing to satiety (Diano et al., 2011). Mitochondrial UCP2
may be a key integrator of these processes, as its activity may limit
ATP and/or ROS production and thereby modulate neuronal
activity.
Collectively, these lines of evidence support the notion that
mitochondrial processes and intermediates in ARC hypothalamic
neurons play fundamental roles in sensing and integrating
metabolic cues and also mediate neuronal function and
associated behavior.
Role of Mitochondrial Fusion Proteins on
Hypothalamic ARC Neurons
Recent research suggests that mitochondrial dynamics, in
addition to constitute a key quality control mechanism, is
also implicated in sensing nutrient fluctuations and promoting
bioenergetic adaptations to meet the cellular metabolic needs. In
general terms, physiological processes associated with enhanced
energy demand and reduced energy supply (acute stress,
starvation, etc.) are characterized by mitochondrial fusion
and coupled respiration. In contrast, physiological situations
associated with decreased energy demand and increased supply
(high nutrient levels, obesity, type 2 diabetes) correlate with
mitochondrial fission and decreased coupling (Liesa and Shirihai,
2013; Gao et al., 2014). Given that hypothalamic POMC and
AgRP neurons are metabolic transceivers, it is reasonable to
speculate that mitochondrial dynamics is an integral part of
the molecular mechanisms by which these neurons sense the
energy/nutritional milieu and mediate specific physiological
actions to maintain energy homeostasis.
Two recent studies, one from our research group, have
investigated mitochondrial dynamics and the role of fusion
proteins Mfn1 and 2 in POMC and AgRP neurons upon energy
balance control in vivo (Schneeberger et al., 2013). Electron
microscopy studies under fasting conditions showed decreased
mitochondria number but unaltered morphology in POMC
neurons, while AgRP neurons exhibited elevated mitochondrial
density and reduced size suggesting enhanced fission. High-fat
diet (HFD) administration reduced mitochondria number but
increased their size and elongation in AgRP neurons, in line
with increased fusion (Dietrich et al., 2013). In contrast, POMC
neuron mitochondrial elongation and network complexity was
reduced, indicating elevated fission (Schneeberger et al., 2013)
(Figure 4). Together, these results demonstrate specific patterns
of mitochondrial dynamics in response to nutrient challenges
in POMC and AgRP neurons, which is consistent with their
divergent physiological functions and fuel usage.
Remarkably, HFD feeding reduced the number of
mitochondria-ER contacts in POMC neurons by ∼50%, a defect
FIGURE 4 | Excess nutrient availability alters ER-mitochondria
contacts and mitochondrial dynamics in POMC and AgRP neurons.
High-fat diet (HFD) administration increases mitochondrial fragmentation and
impairs ER-mitochondria contacts in POMC neurons (A,B). In contrast, AgRP
neurons under HFD conditions show increased fusion and unaltered
ER-mitochondria contacts (C,D).
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that was not observed in the AgRP subpopulation (Figure 4).
Recent reports have shown that Mfn2 is implicated in the
tethering of mitochondria with ER (de Brito and Scorrano, 2008)
and in the modulation of ER stress responses (Papanicolaou
et al., 2012; Sebastian et al., 2012; Munoz et al., 2013). Indeed,
under diet-induced obesity (DIO) conditions hypothalamic
Mfn2 expression was reduced and its overexpression in the
ARC was able to ameliorate the metabolic disturbances and
reduce ER stress markers in the hypothalamus of DIO mice
(Schneeberger et al., 2013). Consistent with these observations,
conditional deletion of Mfn2 in POMC neurons resulted in
a marked obesogenic phenotype as a consequence of loss
of mitochondria-ER contacts and early development of ER
stress-induced leptin resistance (Figure 5). In recent years,
hypothalamic ER stress has emerged as a causal factor in the
development of leptin resistance and obesity (Zhang et al., 2008;
Ozcan et al., 2009) and this study established Mfn2 as a key
molecular determinant connecting these processes. Interestingly,
the number of mitochondria-ER junctions in POMC neurons
may be a potential readout of leptin sensitivity (Schneeberger
et al., 2013; Long et al., 2014). The specificity of this dramatic
obese phenotype was demonstrated by the lack of energy balance
abnormalities in mice lacking the homologous Mfn1 in the same
population of neurons (Schneeberger et al., 2013).
Dietrich and associates (Dietrich et al., 2013) also used genetic
conditional approaches to investigate the roles of Mfn1 andMfn2
in AgRP neurons. The metabolic alterations observed in these
mouse models were minimal under chow diet conditions (only
females showed a slight metabolic improvement). However, a
significant observation was that administration of HFD did not
lead to themitochondrial fusion in AgRP-specific knockout mice,
suggesting that Mfn1- and Mfn2-mediated fusion was required
for the bioenergetic adaptations of this population of neurons to
positive energy balance (Schneeberger et al., 2013). This could be
the consequence of reduced firing rate and increased number of
silent AgRP neurons seen these dietary conditions.
FIGURE 5 | Graphical summary of the consequences of Mfn2 loss in
POMC neurons. (A) Under normal physiological conditions, leptin signaling
in POMC neurons is adequately transmitted, thereby enhancing POMC
transcription in the nucleus (1) and subsequent synthesis in the ER (2).
POMC precursor is sorted into secretory granules and processed into
α-MSH (3). This neuropeptide is then released into target areas by POMC
neuron axonal terminals thus mediating the anorexigenic effects of leptin (4).
(B) Deletion of Mfn2 specifically in POMC neurons causes loss of
ER-mitochondria contacts, thus leading to ER stress which interferes with
proper POMC folding (2). Missfolded POMC precursor can not be adequately
sorted or processed into α-MSH (3). As a consequence, leptin signaling (1)
and leptin-mediated anorexigenic effects are blunted (4). LepR; leptin
receptor; Mfn2: mitofusin 2; POMC: proopiomelanocortin; α.MSH: alpha-
melanocyte stimulating hormone.
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Collectively, and in line with previous studies (Chen et al.,
2007; Papanicolaou et al., 2011, 2012; Lee et al., 2012; Pham
et al., 2012), these results reinforce the idea of non-overlapping
physiological roles for mitofusin proteins and neuron-specific
functions. For example, Mfn2 in POMC neurons is particularly
involved in maintaining mitochondria-ER contacts and in the
modulation of the cellular responses to ER stress, while in AgRP
neurons mediates mitochondrial dynamics. It is interesting to
note that in other neuronal types, but not in POMC and AgRP
neurons, mitofusin proteins are essential for neuron survival and
axon growth (Chen et al., 2007; Lee et al., 2012; Pham et al.,
2012). The precise description of the basis of such divergent
cell-specific biological functions will be of capital importance to
understand the role of mitochondrial dynamics in hypothalamic
neurons upon the regulation of energy balance and metabolism.
These mechanisms will be also important to design potential
targeted therapeutical approaches to counteract highly prevalent
metabolic disorders such as obesity and type-2 diabetes.
Future Perspectives
A major current medical need is the efficient treatment of
prevalent diseases such as obesity, type 2 diabetes, Alzheimer’s
disease, Parkinson’s disease, or Huntington disease. In this
respect, it is relevant to identify druggable proteins that
participate in the pathophysiology of those disorders, and that
permit to stop the progression of the disease or to ameliorate
many of the alterations associated to them.
With the turning of the century we have learnt that alterations
in genes relevant in mitochondrial dynamics are sufficient
to develop diseases, leading to certain forms of CMT and
ADOA. Furthermore, data obtained in the last years support
the view that alterations in mitochondrial dynamics may be
involved in the pathogenesis of neurodegenerative diseases, and
in the hypothalamic dysfunctions leading to dysregulated energy
balance. Ample evidence indicates that some neurodegenerative
disorders are associated with altered metabolic and appetitive
behaviors that may be explained by abnormal hypothalamic
function. Although it is tempting to speculate that such
perturbations are the consequence of defective mitochondrial
dynamics, to date direct experimental evidence has not been
provided. Certainly, there is a need to fully demonstrate the
role of mitochondrial dynamics in the pathogenesis of metabolic
and neurodegenerative diseases, and its potential link, by using
more sophisticated mouse models and in humans. In spite of
these difficulties, we hope that the thorough understanding of
the mechanisms that control mitochondrial dynamics, and the
interaction between mitochondrial and endoplasmic reticulum
will permit to enter into a phase in which some of the
mitochondrial dynamics proteins or regulators are amenable for
pharmacological manipulation.
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